Antibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeability

European Journal of Pharmaceutical Sciences

Volumn 83, Issue , 2016, Pages 45-51

  Stigliani, Mariateresa ^a,c   Haghi, Mehra ^b,c   Russo, Paola ^a   Young, Paul M ^c   Traini, Daniela ^c,d  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Antibiotics; Calu 3; LogP; Lung delivery; Molecular weight; Transport

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; MOXIFLOXACIN; RIFAMPICIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; OCTANOL; WATER;

APPARENT PERMEABILITY; ARTICLE; BRONCHUS MUCOSA; DRUG ABSORPTION; DRUG SOLUBILITY; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; BRONCHUS; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PERMEABILITY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

1-OCTANOL; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; BRONCHI; CELL LINE, TUMOR; CELL SURVIVAL; DRUG ADMINISTRATION ROUTES; EPITHELIAL CELLS; HUMANS; MOLECULAR WEIGHT; PERMEABILITY; WATER;

EID: 84950237874     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.12.010     Document Type: Article

References (19)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. R. Borchardt The application of cell culture systems in drug discovery and development J. Drug Target. 3 1995 179 182
3. J. Brillault, W.V. De Castro, T. Harnois, A. Kitzis, J.C. Olivier, and W. Couet P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model Antimicrob. Agents Chemother. 53 2009 1457 1462
4. M. Bur, H. Huwer, L. Muys, and C.M. Lehr Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique J. Aerosol Med. Pulm. Drug Deliv. 23 2010 119 127
5. H.-J. Cho, P. Balakrishnan, H. Lin, M.-K. Choi, and D.-D. Kim Application of biopharmaceutics classification system (BCS) in drug transport studies across human respiratory epithelial cell monolayers J. Pharm. Investig. 42 2012 147 153
6. H. Eixarch, E. Haltner-Ukomadu, C. Beisswenger, and U. Bock Drug delivery to the lung: permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS) J. Epithelial Biol. Pharmacol. 3 2010 1 14
7. B.I. Florea, M.L. Cassara, H.E. Junginger, and G. Borchard Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3 J. Control. Release 87 2003 131 138
8. D.E. Geller Aerosol antibiotics in cystic fibrosis Respir. Care 54 2009 658 670
9. C. Grainger, L. Greenwell, D. Lockley, G. Martin, and B. Forbes Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier Pharm. Res. 23 2006 1482 1490
10. M. Haghi, P.M. Young, D. Traini, R. Jaiswal, J. Gong, and M. Bebawy Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model Drug Dev. Ind. Pharm. 36 2010 1207 1214
11. M. Haghi, H.X. Ong, D. Traini, and P. Young Across the pulmonary epithelial barrier: integration of physicochemical properties and human cell models to study pulmonary drug formulations Pharmacol. Ther. 144 2014 235 252
12. T.T. Mariappan, and S. Singh Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques Mol. Pharm. 1 2004 363 367
13. N.R. Mathia, J. Timoszyk, P.I. Stetsko, J.R. Megill, R.L. Smith, and D.A. Wall Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats J. Drug Target. 10 2002 31 40
14. C. Mobley, and G. Hochhaus Methods used to assess pulmonary deposition and absorption of drugs Drug Discov. Today 6 2001 367 375
15. H.X. Ong, D. Traini, M. Bebawy, and P.M. Young Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model Antimicrob. Agents Chemother. 57 2013 2535 2540
16. J.I. Pachot, R.P. Botham, K.D. Haegele, and K. Hwang Experimental estimation of the role of P-glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model J. Pharm. Pharm. Sci. 6 2003 1 12
17. S. Scalia, M. Haghi, V. Losi, V. Trotta, P.M. Young, and D. Traini Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery Eur. J. Pharm. Sci. 49 2013 278 285
18. F. Tewes, J. Brillault, W. Couet, and J.C. Olivier Formulation of rifampicin-cyclodextrin complexes for lung nebulization J. Control. Release 129 2008 93 99
19. D. Traini, and P.M. Young Delivery of antibiotics to the respiratory tract: an update Expert Opin. Drug Deliv. 6 2009 897 905